couter

Oct 15, 2026 — Potential Equity Raise / Debt Restructuring
Chart by TradingView

The schedule

  • Thu15Oct

    Anticipated capital event or restructuring announcement due to dwindling cash runway.

  • Thu25Feb

    Full year 2026 results and 2027 outlook, assessing the viability of the long-term nutraceutical commercialization strategy.

  • Fri26Feb

    Q3 2026 financial results, focusing on cost-cutting traction and post-recapitalization operating metrics.

  • Fri28May
  • Fri27Aug

Past

  • Fri28Aug

    Scheduled Q2 2026 earnings report, testing the company's ability to stem severe cash burn against a heavily levered balance sheet.